Navigation Links
MGT Capital Investments, Inc.'s Plan of Compliance Accepted by NYSE AMEX, LLC
Date:8/29/2011

NEW YORK, Aug. 29, 2011 /PRNewswire/ -- MGT Capital Investments, Inc. ("MGT", "we", or "the Company") (AMEX: MGT.BC), a holding company engaged in the medical imaging industry, announced today that NYSE Amex, LLC (the "Exchange") has accepted the Company's plan of compliance (the "Plan") submitted in response to a notice from the Exchange Staff dated June 8, 2011 indicating that the Company was not in compliance with certain continued listing standards as set forth in Part 10 of the Exchange's Company Guide.

Specifically, the Exchange Staff noted that the Company was not in compliance with: (a) Section 1003(a)(i) of the Company Guide, resulting from stockholders' equity on March 31, 2011 of less than $2,000,000 and losses from continuing operations and/or net losses in two of its three most recent fiscal years; (b) Section 1003(a)(ii) of the Company Guide with stockholders' equity of less than $4,000,000 and losses from continuing operations and/or net losses in three of its four most recent fiscal years; and (c) Section 1003(a)(iii) with stockholders' equity of less than $6,000,000 and losses from continuing operations and/or net losses in its five most recent fiscal years.  The Company was afforded the opportunity to submit the Plan to the Exchange and on July 15, 2011 presented the Plan to the Exchange.  

On August 23, 2011, the Exchange notified the Company that it had accepted the Plan and granted the Company an extension until December 8, 2012 to regain compliance with Sections 1003(a) (i)-(iii) of the Company Guide.  The Company will be subject to periodic review by Exchange Staff during the extension period.  Failure to make progress consistent with the Plan or to regain compliance with the continued listing standards by the end of the extension period could result in the Exchange initiating delisting proceedings pursuant to Section 1009 of the Company Guide.

The Exchange further notified the Company that
'/>"/>

SOURCE MGT Capital Investments, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CVS Caremark Corporation Announces Receipt of Requisite Consents, Termination of Replacement Capital Covenant and Expiration of Consent Solicitation Relating to its 6.125% Senior Notes due August 15, 2016 (CUSIP NO. 126650BE9)
2. MGT Capital Investments, Inc. Provides Update on Recent Developments
3. KPS Capital Partners to Sell Attends Healthcare, Inc. to Domtar Corporation for $315 Million
4. Vycor Medical, Inc. Completes Final Close on Equity Capital Raise
5. HASCO Medical Chairman Provides $2 Million in Capital and a Personal Guarantee on Additional $2 Million Promissory Note
6. Foundation Venture Capital Group Investment Shows Promise in Diagnosis of Alzheimers Disease Using a Drop of Blood
7. Report on HIV Prevention Research Funding Says New Investment Critical to Capitalize on HIV Prevention Research Breakthroughs
8. CSA Medical Completes $12.6 Million Series A Financing With Additional Venture Investment From Blue Heron Capital
9. ECRI Institute Launches Market Analytics Tool to Help Hospitals Make More Informed Capital Purchasing Decisions
10. Boston Scientific to Donate $1 Million to ASGEs IT & T Capital Campaign to Build a New State-of-the-Art GI Training Center
11. SeraCare Acknowledges Receipt of Unsolicited Proposal from MSMB Capital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Research and Markets ( ... "Investigation Report on China,s Tobramycin Market, 2010-2019" report ... antibiotic whose eye drop and ointment are the most ... or inflammation caused by eye infection. Currently, dozens of ... to produce tobramycin, among which the Top 5 are ...
(Date:8/28/2015)... Research and Markets ( ... "Investigation Report on China,s Insulin Aspart Market, ... Developed by Novo Nordisk, insulin aspart (under the ... for the treatment of diabetes. Compared with human ... analog, starts working fast and reports higher peak ...
(Date:8/28/2015)... 28, 2015  IP Shakti, LLC, today announced that it ... Logo - http://photos.prnewswire.com/prnh/20150827/261551LOGO ... new corporate identity signifies our transformation into a company focused ... platform for patent claim validity." ... proprietary AIA Shield™ platform, the Company commenced a corporate re-branding ...
Breaking Medicine Technology:Investigation Report on China's Tobramycin Market, 2015-2019 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2
... RATON, Fla., Sept. 15 Watermark Medical , ... the sleep-disordered breathing market, has expanded the market reach ... strategic alliances with three leading sleep solution providers in ... SleepQuest , a national provider of comprehensive sleep apnea ...
... Sept. 15 ViroPharma Incorporated (Nasdaq: VPHM ... Phase 1 study of VP20621 (non-toxigenic Clostridium difficile ... Clostridium difficile infections (CDI), a common and dangerous ... of antibiotic medications.  VP20621 contains the spores of a ...
Cached Medicine Technology:Three Leading Sleep Solution Providers Choose Watermark Medical's Web-Enabled Home Sleep Testing Solutions 2Three Leading Sleep Solution Providers Choose Watermark Medical's Web-Enabled Home Sleep Testing Solutions 3Three Leading Sleep Solution Providers Choose Watermark Medical's Web-Enabled Home Sleep Testing Solutions 4ViroPharma Announces Presentation of Data from Non-Toxigenic Clostridium difficile (VP20621) Phase 1 Study 2ViroPharma Announces Presentation of Data from Non-Toxigenic Clostridium difficile (VP20621) Phase 1 Study 3ViroPharma Announces Presentation of Data from Non-Toxigenic Clostridium difficile (VP20621) Phase 1 Study 4ViroPharma Announces Presentation of Data from Non-Toxigenic Clostridium difficile (VP20621) Phase 1 Study 5ViroPharma Announces Presentation of Data from Non-Toxigenic Clostridium difficile (VP20621) Phase 1 Study 6
(Date:8/28/2015)... ... ... For Dallas, the time is nearing for the annual Heart Walk, and ... The American Heart Association hosts their well-known Heart Walk to raise money in awareness ... can be made. Walkers can participate in the cause and someone can also donate, ...
(Date:8/28/2015)... ... August 28, 2015 , ... On May 30th, 2015, Best Drug ... of the “Music With A Mission” benefit concert in Mendon, IL. Held in the ... raise money to support music education programs in the underfunded local school districts of ...
(Date:8/28/2015)... ... August 28, 2015 , ... Altima Technologies, Inc., the ... and data center assets and audio-video devices, recently released Visio Stencils for the ... HP ProLiant Gen9, EMC VNX Series , Super Micro Computer SuperStorage, Hitachi Data ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... three-year accreditation for its adolescent residential, counseling, day treatment and intensive family based ... meets international standards for quality and its pursuit of excellence. As a nonprofit ...
(Date:8/28/2015)... Northridge, CA (PRWEB) , ... August 28, 2015 , ... ... special price on Zoom teeth whitening. For just $199, patients can currently receive a ... to traditional in-office teeth whitening procedures, but it includes a number of unique features ...
Breaking Medicine News(10 mins):Health News:North Central Surgical Center’s Subsidiary Participates in Walk 2Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 3Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2
... , , , , ... Cleveland Clinic Lou Ruvo Center for Brain Health welcomes ... highly touted model of patient-focused care. , , ... Health is a highly specialized clinical center designed to advance the research, early ...
... Va., July 13 Long term care costs in most ... putting significant financial pressure on those in or near retirement. ... Genworth offers a suite of insurance products to help people ... in Arkansas can take advantage of a new program designed ...
... , , , ... BMRN ) announced today that patient enrollment has been ... 6-sulfatase (GALNS), intended for the treatment of the lysosomal storage disorder ... company expects to report initial results in the first half of ...
... of lives, researchers say , MONDAY, July 13 (HealthDay ... have died because of safety restrictions on the ... study suggests. , Finnish researchers concluded that clozapine is ... antipsychotics. , For this study, the researchers looked at ...
... , LOS ALTOS, Calif., July 13 InteKrin ... as Chief Business Officer. Most recently, Mr. Parker served as ... Goldman, Sachs & Co. Over the past ten years, Mr. ... which time he advised many of the biotechnology industry,s leading companies. ...
... (NYSE: HAE ) will announce its Q1FY10 earnings on August 3, ... , Webcast Link: http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=72118&eventID=2323195 ... from August 3, 2009 after 1:00 pm to August 10, 2009. , ... Julie Fallon, Tel. (781) 356-9517, Alt. Tel. ...
Cached Medicine News:Health News:Cleveland Clinic Lou Ruvo Center for Brain Health Opens for Business 2Health News:Cleveland Clinic Lou Ruvo Center for Brain Health Opens for Business 3Health News:Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Arkansas AARP Members 2Health News:Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Arkansas AARP Members 3Health News:Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Arkansas AARP Members 4Health News:Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Arkansas AARP Members 5Health News:Patient Enrollment Complete for Phase I/II Clinical Trial for GALNS for Morquio A Syndrome 2Health News:Patient Enrollment Complete for Phase I/II Clinical Trial for GALNS for Morquio A Syndrome 3Health News:Patient Enrollment Complete for Phase I/II Clinical Trial for GALNS for Morquio A Syndrome 4Health News:Schizophrenia Drug Got Bad Rap 2Health News:InteKrin Therapeutics Announces Appointment of Geoffrey M. Parker as Chief Business Officer 2
The Surgiflex WAVE XP couples the state-of-the-art Surgiflex WAVE Probe with the convenience of a truly portable battery-powered pump....
The original battery-operated suction and irrigation system features a new ergonomic hand piece and superior performance characteristics that have increased the overall flow rate....
... The first step to treatment is ... is an innovative and quick, patient-friendly tool ... female urinary incontinence while minimizing patient discomfort. ... device features a new type of urethral ...
...
Medicine Products: